By Sabela Ojea

Lucira Health Inc. on Friday received the U.S. Food and Drug Administration's emergency use authorization for its Covid-19 and Flu diagnostic test. Shares of the company, which provides at-home molecular tests and tele-health services for Covid-19, jumped 180% in after-hours trading.

Tegna Inc.'s $5.4 billion proposed sale to hedge fund Standard General L.P. will be further examined by an administrative law judge, the U.S. Federal Communications Commission said. Shares of the TV broadcaster dropped 26% in after-hours trading.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

February 24, 2023 18:43 ET (23:43 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Lucira Health Charts.
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Lucira Health Charts.